GAIA BioMedicine Inc.
PrivateLast Round
Series D
Jul 11, 2025
Total Funding Raised
$30.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GAIA BioMedicine Inc. is a biopharmaceutical company that develops off-the-shelf, NK-like cell therapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GAIA BioMedicine Inc. Comparables
Compare GAIA BioMedicine Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wugen | 80% | |
| Healios K.K. | 79% | |
| Celularity Inc. | 77% |
GAIA BioMedicine Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 11, 2025 | ||||
| Series B | Sep 21, 2021 | ||||
| Series A | Feb 4, 2020 | ||||
| Strategic | Feb 13, 2018 |
GAIA BioMedicine Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEJ Capital | Series B |
| JIC Venture Growth Investments | Series D |
| Mitsubishi UFJ Capital | Series A |
| UntroD Capital Japan Inc. | Series D |
| Osaka University Venture Capital Co., Ltd. | Series B |
| SBI Investment Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 111% MoM.
- Apr 20, 2026
Monthly visitors grew 255% MoM, from 11 to 39.
GAIA BioMedicine Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GAIA BioMedicine Inc.'s valuation, stock price, and market status.
Is GAIA BioMedicine Inc. a public or private company?
GAIA BioMedicine Inc. is a private company.
What is the current stock price of GAIA BioMedicine Inc.?
GAIA BioMedicine Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is GAIA BioMedicine Inc. worth (valuation)?
Valuation information for GAIA BioMedicine Inc. is not publicly available.
Can I buy GAIA BioMedicine Inc. stock?
GAIA BioMedicine Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GAIA BioMedicine Inc.'s last funding round?
GAIA BioMedicine Inc.'s most recent funding round was Series D on July 11, 2025.
Who are the main investors in GAIA BioMedicine Inc.?
Key investors in GAIA BioMedicine Inc. include Mitsubishi UFJ Capital, UntroD Capital Japan Inc..
Will GAIA BioMedicine Inc. IPO soon?
No public IPO plans have been announced for GAIA BioMedicine Inc..
How can I track GAIA BioMedicine Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GAIA BioMedicine Inc.'s secondary market activity and sign up for updates.